In summary, BiP mRNA and protein levels are significantly associated with PAM50 breast cancer molecular subtype and the three immunohistochemical markers used in breast cancer diagnosis (ER, PR, and HER2). The gene discussed is ERBB2; the disease is breast carcinoma.